BioCentury | Sep 24, 2012
Company News

BlueGnome, Illumina deal

Illumina acquired cytogenetic diagnostic company BlueGnome for an undisclosed sum. BlueGnome offers its CytoChip genomic-based test to screen for genetic abnormalities associated with developmental delay and complex leukemias. BlueGnome's 24sure test is a pre-implantation test...
BioCentury | Jul 2, 2012
Clinical News

24sure: Phase II started

BlueGnome said investigators began a U.S. Phase II trial in about 200 patients to evaluate pre-implantation diagnosis using 24sure for single embryo in vitro fertilization. BlueGnome Ltd. , Fulbourn, U.K. Product: 24sure Business: Diagnostic Molecular target:...
Items per page:
1 - 2 of 2